Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum
References (17)
- et al.
A long-lasting cholinesterase inhibitor affecting neural and behavioral processes
Pharmac. Biochem. Behav.
(1987) - et al.
Basal acetylcholine release in freely moving rats detected by on-line trans-striatal dialysis: pharmacological aspects
Life Sci.
(1988) - et al.
The effect of acetylcholinesterase inhibition on the release of acetylcholine from the striatum in vivo: interaction with autoreceptor responses
Neurosci. Lett.
(1990) - et al.
Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain
Neuropharmacology
(1989) - et al.
Effects of E2020 on the extracellular level of acetylcholine in the rat cerebral cortex measured by microdialysis without addition of cholinesterase inhibitor
Eur. J. Pharmac.
(1990) - et al.
Chemical sensitivity of neurons in long-isolated slabs of cat cerebral cortex
Electroenceph. clin. Neurophysiol.
(1970) - et al.
Determination of basal acetylcholine release in vivo by rat brain dialysis with a U-shaped cannula: Effect of SM-10888, a putative therapeutic drug for Alzheimer's disease
Neurosci. Lett.
(1991) - et al.
Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects
Drug Dev. Res.
(1988)
There are more references available in the full text version of this article.
Cited by (44)
The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum
2012, Neurochemistry InternationalCitation Excerpt :Secondly, we used doses that have been proven to inhibit PREP by 60–80% for 5 h. Most importantly, Toide and co-workers used an extremely high concentration (10 μM) of the AChE inhibitor physostigmine in the perfusate in order to obtain detectable quantities of ACh. Physostigmine is known to elevate brain ACh efflux especially at higher concentrations (Messamore et al., 1993), and this manipulation could well account for the differences between the present report and that of Toide et al. (1995a). In recent years, many improvements in the sensitivity of HPLC/MS assays for ACh have been introduced, thus permitting a reduction of the perfusate concentrations of the AChE inhibitors from the micromolar to the present nanomolar range.
Effects of T-82, a new quinoline derivative, on cholinesterase activity and extracellular acetylcholine concentration in rat brain
2002, Japanese Journal of Pharmacology
Copyright © 1993 Published by Elsevier Ltd.